$NPCE SEC Filings

Filed On	Filing
25 Sep 2026	Form 4: Morrell Martha, CHIEF MEDICAL OFFICER Gave up 335 shares to cover exercise price or tax ($4.68K)
21 Sep 2026	Form 4: Williams Patrick F., Chief Financial Officer Gave up 1,162 shares to cover exercise price or tax ($16.6K)
04 Sep 2026	SCHEDULE 13G/A
04 Sep 2026	Form 4: Becker Joel, Director Gave up 1,310 shares to cover exercise price or tax ($19.3K)
28 Aug 2026	Form 4: Morrell Martha, CHIEF MEDICAL OFFICER Gave up 358 shares to cover exercise price or tax ($5.06K)
28 Aug 2026	Form 4: Becker Joel, Director Gave up 1,126 shares to cover exercise price or tax ($15.9K)
14 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	10-Q
11 Aug 2026	8-K: Results of Operations and Financial Condition
28 Jul 2026	8-K: Regulation FD Disclosure
25 Jun 2026	Form 4: Morrell Martha, CHIEF MEDICAL OFFICER Gave up 335 shares to cover exercise price or tax ($5.43K)
22 Jun 2026	Form 4: Geiger Uri, Director Received 789 shares as a grant or award ($12.3K)
22 Jun 2026	Form 4: Fischer Frank M, Director Received 1,467 shares as a grant or award ($22.9K)
22 Jun 2026	Form 4: Kumar Rakhi, Director Received 989 shares as a grant or award ($15.5K)
08 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
05 Jun 2026	Form 4: Huennekens R Scott, Director Received 2,890 shares as a grant or award · Granted 5,368 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Fischer Frank M, Director Received 2,890 shares as a grant or award · Granted 5,368 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Geiger Uri, Director Received 2,890 shares as a grant or award · Granted 5,368 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Kumar Rakhi, Director Received 2,890 shares as a grant or award · Granted 5,368 Stock Option (Right to Buy)
05 Jun 2026	Form 4: Ryan Renee, Director Received 2,890 shares as a grant or award · Granted 5,368 Stock Option (Right to Buy)

Comments